Naproxen
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Aleve, Anaprox, Bonyl, DL Naproxen, DL-Naproxen, Diocodal, Dysmenalgit, Ec-naprosyn, Equiproxen, Floginax, Laraflex, Laser, Mnpa, Naixan, Naprelan, Napren, Naprium, Naprius, Naprosine, Naprosyn, Naprosyne, Naproxen Sodium, Naprux, Naxen, Naxyn, Niaxan, Nycopren, Panoxen, Pranoxen, Prexan, Proxen, Proxine, Reuxen, Veradol, Xenar x
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
Geriatric Patients
Studies indicate that although total plasma concentration of Naproxen is unchanged, the unbound plasma fraction of Naproxen is increased in the elderly. Caution is advised when high doses are required and some adjustment of dosage may be required in elderly patients. As with other drugs used in the elderly, it is prudent to use the lowest effective dose.
Patients with Moderate to Severe Renal Impairment
Naproxen-containing products are not recommended for use in patients with moderate to severe and severe renal impairment (creatinine clearance < 30 mL/min).
Rheumatoid Arthritis, Osteoarthritis and Ankylosing Spondylitis
- 275 mg (Naproxen 250 mg with 25 mg sodium) twice daily
- or 550 mg (Naproxen 500 mg with 50 mg sodium) twice daily
For more information on dosing please refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Naproxen
Return to top
Publication Resources
Most Recent Articles on Naproxen
Review Articles on Naproxen
Articles on Naproxen in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Naproxen
Return to top
Trial Resources
Ongoing Trials with Naproxen at Clinical Trials.gov
Trial Results with Naproxen
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Naproxen
Cochrane Collaboration on Naproxen
Cost Effectiveness of Naproxen
Return to top
Media Resources
Powerpoint Slides on Naproxen
Images of Naproxen
Podcasts & MP3s on Naproxen
Videos on Naproxen
Return to top
Patient Resources
Patient Resources on Naproxen
Discussion Groups on Naproxen
Patient Handouts on Naproxen
Blogs on Naproxen
Naproxen in the News
Naproxen in the Marketplace
Return to top
International Resources
Naproxen en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.

